Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.

Lee S, Cimica V, Ramachandra N, Zagzag D, Kalpana GV.

Cancer Res. 2011 May 1;71(9):3225-35. doi: 10.1158/0008-5472.CAN-10-2167. Epub 2011 Apr 26.

2.

INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors.

Morozov A, Lee SJ, Zhang ZK, Cimica V, Zagzag D, Kalpana GV.

Clin Cancer Res. 2007 Aug 15;13(16):4721-30.

3.

The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.

Caramel J, Medjkane S, Quignon F, Delattre O.

Oncogene. 2008 Mar 27;27(14):2035-44. Epub 2007 Oct 8.

PMID:
17922027
4.

Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D, Kalpana GV.

Mol Cell Biol. 2002 Aug;22(16):5975-88.

5.

SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.

Kuwahara Y, Wei D, Durand J, Weissman BE.

Mol Cancer Res. 2013 Mar;11(3):251-60. doi: 10.1158/1541-7786.MCR-12-0390. Epub 2013 Jan 30.

6.

P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.

Oruetxebarria I, Venturini F, Kekarainen T, Houweling A, Zuijderduijn LM, Mohd-Sarip A, Vries RG, Hoeben RC, Verrijzer CP.

J Biol Chem. 2004 Jan 30;279(5):3807-16. Epub 2003 Nov 6.

7.

Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.

Uno K, Takita J, Yokomori K, Tanaka Y, Ohta S, Shimada H, Gilles FH, Sugita K, Abe S, Sako M, Hashizume K, Hayashi Y.

Genes Chromosomes Cancer. 2002 May;34(1):33-41.

PMID:
11921280
8.

Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.

Kato H, Honma R, Sanda T, Fujiwara T, Ito E, Yanagisawa Y, Imai J, Okamoto T, Watanabe S.

Biochem Biophys Res Commun. 2007 Sep 28;361(3):580-5. Epub 2007 Jul 25.

PMID:
17669367
9.

The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.

Medjkane S, Novikov E, Versteege I, Delattre O.

Cancer Res. 2004 May 15;64(10):3406-13.

10.

hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.

Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O, Aurias A.

Cancer Res. 1999 Jul 1;59(13):3152-6.

11.

RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.

Caramel J, Quignon F, Delattre O.

Cancer Res. 2008 Aug 1;68(15):6154-61. doi: 10.1158/0008-5472.CAN-08-0115.

12.
13.

Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.

Fujisawa H, Misaki K, Takabatake Y, Hasegawa M, Yamashita J.

J Neurooncol. 2005 Jun;73(2):117-24.

PMID:
15981100
14.

The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.

Albanese P, Belin MF, Delattre O.

Eur J Cancer. 2006 Sep;42(14):2326-34.

PMID:
16908131
15.

Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells.

Ae K, Kobayashi N, Sakuma R, Ogata T, Kuroda H, Kawaguchi N, Shinomiya K, Kitamura Y.

Oncogene. 2002 May 9;21(20):3112-20.

16.

Human SNF5/INI1, a component of the human SWI/SNF chromatin remodeling complex, promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation.

Ray A, Mir SN, Wani G, Zhao Q, Battu A, Zhu Q, Wang QE, Wani AA.

Mol Cell Biol. 2009 Dec;29(23):6206-19. doi: 10.1128/MCB.00503-09. Epub 2009 Oct 5.

17.

hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.

Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, Pierron G, Sainte-Rose C, Bergeron C, Bouvier R, Rialland X, Laurence V, Michon J, Sastre-Garau X, Delattre O.

J Pathol. 2007 Feb;211(3):323-30.

PMID:
17152049
18.

Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.

Alarcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV.

Oncogene. 2006 Feb 2;25(5):722-34.

PMID:
16302003
19.

Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.

Boese A, Sommer P, Holzer D, Maier R, Nehrbass U.

J Gen Virol. 2009 Oct;90(Pt 10):2503-12. doi: 10.1099/vir.0.013656-0. Epub 2009 Jun 10.

PMID:
19515827
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk